Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
NanoValent Pharmaceuticals
company
About
NanoValent Pharmaceuticals is a pharmaceutical company.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $510K
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2006
- Number Of Employee
- 1 - 10
- Operating Status
- Active
NanoValent Pharmaceuticals develops novel therapeutic options with enhanced target and delivery characteristics. Their technology will significantly enhance therapeutics. It possesses an experienced core management team with a proven track record of success, supported by a strong clinical and operational capability.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$510K
NanoValent Pharmaceuticals has raised a total of
$510K
in funding over 2 rounds. Their latest funding was raised on
Sep 16, 2013 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 16, 2013 | Grant | $510K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
NanoValent Pharmaceuticals is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
